Elizabeth Spooner

Biographic Data

ID7605555
NAMEElizabeth Spooner
GIVEN NAMESElizabeth
FAMILY NAMESpooner
SIGNATURESPOONER E
AFFILIATIONSSouth African Medical Research Council
ORCID0000-0002-1498-8131
VERIFIEDYes
TOTAL WORKS6
TOTAL CITATIONS0
WORKS AS AUTHOR6
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2025
H-INDEX0

  • Sars-CoV-2 seroprevalence among learners in grades 1–7, their parents and teachers in KwaZulu-Natal, South Africa

    Open AccessReshmi Dassaye, Terusha Chetty et al.ARTICLEFrontiers in Public Health2025

    Introduction: There is limited information on SARS-CoV-2 seroprevalence among children and adolescents in LMIC school settings. We aimed to assess (1) the seroprevalence of SARS-CoV-2 antibodies, (2) prevalence of self-reported or confirmed SARS-CoV-2 prior infections and, (3) COVID-19 symptoms (including long-COVID) among a cohort of primary school learners, their parents and teachers in a semi-rural school setting approximately 3-years into the…

  • Group-based Self-Help Plus, Problem Management Plus and pre-exposure prophylaxis to improve mental health and reduce HIV risk in survivors of rape in KwaZulu-Natal, South Africa

    Open AccessJani Nöthling, Samantha Willan et al.ARTICLESSM - Mental Health2025

    Gender-based violence (GBV) and HIV are highly prevalent in South Africa and are significant public health problems. Rape is a risk factor for both HIV acquisition and adverse mental health outcomes. Post-rape interventions targeting HIV and mental health are needed to mitigate risk and aid recovery. Self-Help Plus (SH+) and Problem Management Plus (PM+) are lay counsellor-facilitated, group-based mental health interventions. We adapted them for …

  • Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa

    Open AccessNigel Garrett, Tarylee Reddy et al.ARTICLEPLOS Global Public Health2024

    Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after prime with Ad26.COV2.S (SHERPA) trial evaluated a mRNA-1273 boost after Ad26.COV2.S priming in South Africa. SHERPA was a single-arm, open-label, phase 3 study nested in the Sisonke implementation trial of 500000 healthcare…

  • Getting to under 1% vertical HIV transmission

    Open AccessBrodie Daniels, Elizabeth Spooner et al.ARTICLEBMJ Global Health2022

    We report here on the transmission of HIV in a cohort of breastfeeding infants enrolled in a prevention of mother to child HIV transmission (PMTCT) programme at the epicentre of the HIV pandemic. South Africa implemented option B+ for PMTCT in 2015. Between 2013 and 2018, we enrolled 1219 infants born to HIV positive women into a non-inferiority trial assessing the current cotrimoxazole prophylaxis guidelines for HIV-exposed uninfected infants. B…

  • Point-of-care CD4 testing

    Open AccessElizabeth Spooner, Tarylee Reddy et al.ARTICLEJournal of Global Health2022

    BACKGROUND: ) persists, and CD4 count testing is being overlooked since universal test-and-treat was implemented. Point-of-care CD4 testing could address this gap and assure differentiated care to these vulnerable patients with low CD4 counts. METHODS: A time randomised implementation trial was conducted, enrolling 603 HIV positive non-ART, not pregnant patients at a primary health care clinic in Durban, South Africa. Weeks were randomised to eit…

  • Point-of-care HIV testing best practice for early infant diagnosis

    Open AccessElizabeth Spooner, Kerusha Govender et al.ARTICLEBMC Public Health2019

    ISRCTN38911104 registered 9 January 2018 - retrospectively registered